Select Page

FSR is so grateful to our Corporate Advisory Committee members who are dedicated to advancing initiatives and research for sarcoidosis! The Corporate Advisory Committee serves as a sounding board for FSR leadership. The Corporate Advisory Committee provides the opportunity for open dialogue among industry partners in the sarcoidosis space to explore topics including research and drug development, access challenges for patients, and healthcare legislation. This committee represents a prestigious group of corporations committed to advancing initiatives and research for sarcoidosis and works collaboratively among the group and with FSR. Membership for the FSR Corporate Advisory Committee includes the following benefits:

  • Networking opportunities with FSR’s national network of sarcoidosis patients as well as FSR’s Patient Advisory Committee, FSR’s Board, and FSR Scientific Advisory Board
  • Collaborative discussions and communications around organization updates and initiatives
  • Exclusive invitations to FSR-hosted symposiums and annual leadership meetings

Thank you to the following partners who have become members of FSR’s Corporate Advisory Committee!






To learn how you can join FSR’s Corporate Advisory Committee, please contact Angela O’Malley at

Translate »